Tuesday, April 25, 2017

Wednesday, April 26, 2017

SESSION 1: Progress in Inhaled Drug Development

SESSION 2: Workshops

  • Sponsor: Aptar Pharma
    Moderator: Gerallt Williams, Ph.D.

    2:00 p.m. - 6:00 p.m.

    The following companies each sponsored 60-minute interactive presentations on new technologies and services related to nasal and pulmonary drug delivery. Meeting participants could select and attend three of these sessions.

    3M Drug Delivery Systems
    The New Future - Introducing the Next Generation pMDI

    The Critical Role of Primary Packaging within the Qualification of Dry Powder Inhalers

    Aptar Pharma & Propeller Health
    Using Connected pMDIs to Monitor Inhaler Use and Drive Better Quality of Care

    Engineered Particle Platform for Rapid Assessment of Inhaled Formulations: In Vitro and In Vivo Correlations

    Centre of Postgraduate Medical Education (CMKP), Warsaw
    Optimizing Dose Delivery of Nebulized Drugs

    Functional Respiratory Imaging (FRI): Assessment of Lung Health to Optimize Respiratory Drug Delivery

    H&T Presspart & Cohero Health
    Smart Inhalers of the Future

    Harro Höfliger Verpackungsmaschinen
    Novel Inhaler for Controlled Pulmonary Delivery of Cannabis: Therapeutic and Technical Aspects

    Advanced Characterization and Design of Inhalable Formulations

    Realizing the Benefits of Connected Health in Respiratory Drug Delivery

    Proveris Scientific
    Using a Novel Rapid Screening Technique to Streamline pMDI Formulation and Device Development

    Impact of Capsule Type on the Aerodynamic Performance of Dry Powder Formulations for Inhalation

Thursday, April 27, 2017

SESSION 3: Can Connected Devices Improve Respiratory Outcomes?

SESSION 4: Posters on the Podium

SESSION 5: Changing Regulations in Europe

SESSION 6: Achieving Deposition Equivalence

Friday, April 28, 2017

SESSION 7: Novel Approaches to Characterize Aerosol Dynamics

SESSION 8: Designing Inhalation Products in a Quality by Design Era

Back to Top